Recent Updates
Recently added Catalysts
URGN

UroGen Pharma to Present at Upcoming Investor Conferences

Key Takeaway: PRINCETON, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in the following investor

Full Press Release Details

PRINCETON, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in the following investor conferences in May.
Bank of America Health Care Conference 2026
Date / Time: May 13th, at 11:15 AM ET
Format: 1x1’s
Location: Las Vegas, NV
Webcast Link: Here
HC Wainwright 4 th Annual BioConnect Investor Conference
Date / Time: May 19th, at 10:30 AM ET
Format: 1x1’s
Location: New York, NY
Webcast Link: Here
TD Cowen 7 th Annual Oncology Innovation Summit
Date / Time: May 26th, at 10:30 AM ET
Location: Virtual
Webcast Link: Here
The webcasts from the conference will also be available on UroGen’s Investor Relations website. A replay will be available for approximately 90 days.
About UroGen Pharma Ltd.
Senior Director, Investor Relations
609-460-3588 ext. 1093
Director, Corporate Communications
609-460-3566 ext. 1083

Tags

Last updated: May 7, 2026